New global analysis has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased dramatically....
Moderna announced Thursday morning that it's asking the FDA to approve its COVID vaccine for kids under 6 years old. If authorized for emergency use, it would become the first eligible vaccine for kids younger than 5....
Artificial Intelligence (AI) has the power to ensure clinical trials are unbiased from the outset and draw better inferences about the different responses between men and women from clinical trials....
In honor of “Medical Laboratory Professionals Week” (April 24-30), we at the University of Wisconsin–Madison Clinical Research Office would like to express our gratitude to all of the lab professionals in our clinical research community!...
Early clinical trials suggest vaccines that activate T cells work better and faster and may protect people with weakened immune systems....
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move pharmaceutical therapies from the lab into the clinic....
What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome?...
We must apply lessons learned in the development of the COVID-19 vaccines, including community engagement strategies and innovative clinical trial design, to longstanding public health challenges such as TB....
Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence and machine learning are just a few of the reasons to be excited about the future of clinical research....
The US Food and Drug Administration (FDA) is recommending sponsors include a plan to increase diversity when proposing clinical trial designs for investigational products to agency reviewers....
